Activated downstream protein S6 in the mTOR signaling pathway often regulates cell proliferation and survival, thus diminishing the inhibitory effect of DDP on NSCLC, with resultant resistance to DDP. This evidence concerns the gene MTOR and non-small cell lung carcinoma.